Skip to main content
ArticleOPEN ACCESS

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

The Lancet
DOI: 10.1016/S0140-6736(21)00448-7
214Citations
Citations of this article
353Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Cite

CITATION STYLE

APA

Amit, S., Regev-Yochay, G., Afek, A., Kreiss, Y., & Leshem, E. (2021, March 6). Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. The Lancet. Elsevier B.V. https://doi.org/10.1016/S0140-6736(21)00448-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free